financetom
Business
financetom
/
Business
/
Oracle Provides Fiscal Q4, Long-Term Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oracle Provides Fiscal Q4, Long-Term Guidance
Mar 11, 2025 3:13 AM

05:56 AM EDT, 03/11/2025 (MT Newswires) -- Oracle (ORCL) expects fiscal Q4 non-GAAP earnings of $1.61 to $1.65 per share, Chief Executive Safra Catz said late Monday.

The company expects revenue for the quarter to grow 8% to 10% in US dollars at current exchange rates, Catz said on an earnings conference call.

"We remain very confident and committed to total cloud infrastructure revenue for fiscal year 2025 growing faster than the 50% reported last year and it will be even faster for fiscal year 2026, likely a lot faster," Catz told analysts.

"Our confidence in meeting our $66 billion revenue target for FY 2026 is now stronger than ever," Catz said. "I now expect that our fiscal year 2027 growth rate will be around 20%, which is even higher than I previously guided."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly to Acquire Eye Gene Therapy Developer Adverum Biotechnologies
Eli Lilly to Acquire Eye Gene Therapy Developer Adverum Biotechnologies
Oct 24, 2025
11:14 AM EDT, 10/24/2025 (MT Newswires) -- Eli Lilly ( LLY ) has agreed to acquire Adverum Biotechnologies ( ADVM ) , which is developing a therapy to treat vision loss, in a deal worth up to $12.47 per share, the companies said in a joint statement Friday. Adverum's lead product candidate, Ixo-vec, is in a phase 3 trial for...
Intel's Q3 'Significant Upside' is Encouraging, Morgan Stanley Says
Intel's Q3 'Significant Upside' is Encouraging, Morgan Stanley Says
Oct 24, 2025
11:13 AM EDT, 10/24/2025 (MT Newswires) -- Intel's ( INTC ) significant upside in its Q3 results released late Thursday, especially in margins, was encouraging, Morgan Stanley said in a note Friday. The company's Q3 gross margins were notably better, and there are strong conditions evident throughout the businesses, the note said, adding demand for microprocessors is pretty good. The...
Molina Healthcare Sees Medicaid, Marketplace Trends Weighing on 2025 Results, Deutsche Bank Says
Molina Healthcare Sees Medicaid, Marketplace Trends Weighing on 2025 Results, Deutsche Bank Says
Oct 24, 2025
10:28 AM EDT, 10/24/2025 (MT Newswires) -- Molina Healthcare ( MOH ) expects downward trends for Medicaid and its Marketplace business to weigh on its 2025 results, with Medicaid margin to continue dropping through 2026, Deutsche Bank said in a Friday note. The company reported disappointing Q3 results, said the investment firm, as its adjusted earnings fell to $1.84 per...
Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections
Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections
Oct 24, 2025
Eli Lilly and Company ( LLY ) and Adverum Biotechnologies, Inc. ( ADVM ) on Friday announced that they have entered into a definitive agreement under which Lilly will acquire Adverum Biotechnologies ( ADVM ), including its lead product, Ixo-vec. Acquisition Terms and Contingent Value Rights (CVR) Under the merger terms, Eli Lilly ( LLY ) will launch a tender...
Copyright 2023-2026 - www.financetom.com All Rights Reserved